secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eton Pharmaceuticals, Inc. (ETON)
CIK:        0001710340
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001437749-24-012443
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
LLM model:  deepseek-v4-flash:cloud@v2

Eton cancels $13.1M equity raise and credit expansion after losing Eiger auction
--------------------------------------------------------------------------------

- Planned to issue 1,287,500 common shares at $3.50 and pre-funded warrants for 2,462,500 shares.
- Also planned to expand credit facility from $21.9M to $27.0M with a lender warrant for 358,976 shares.
- All transactions were contingent on winning an auction for Eiger BioPharmaceuticals assets on April 17, 2024.
- Eton was not the successful bidder; therefore all agreements were cancelled and are void.
- No underwriters were used; the offerings were exempt under Regulation D Rule 506.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710340/000143774924012443/0001437749-24-012443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710340/000143774924012443/eton20240412_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-012443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer